MedTech Industry Dynamics
MedTech Industry Dynamics
Japan’s Ministry of Health, Labour and Welfare has approved Novocure’s Optune Pax for adult patients with unresectable locally advanced pancreatic cancer, used alongside gemcitabine and nab-paclitaxel, following positive results from the Phase 3 PANOVA-3 trial.
Read MoreMedtronic has launched ApexCut blades in Japan, a next-generation powered ENT instrumentation designed to reduce clogging and improve surgical efficiency in paranasal sinus surgery, following regulatory approval in May 2026.
Read MoreUltimion features a cadmium zinc telluride photon-counting detector capable of delivering ultra-high resolution and spectral images in a single scan, with a planned April 17 launch in Japan following clinical research at the National Cancer Center.
Read MoreOlympus has introduced a new NBI+TXI observation mode for its EVIS X1 endoscopy system, combining two advanced imaging technologies to enhance lesion visibility and diagnostic accuracy in gastrointestinal and respiratory care.
Read MoreGunze Medical will exclusively distribute HistoSonics’ noninvasive histotripsy therapy platform in Japan, expanding access to advanced ultrasound-based cancer treatment.
Read MoreiTaperloc® Complete and iG7™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint Infection after total joint replacement
Read MoreJapan’s Ministry of Health, Labour and Welfare approved Optune Lua for use with PD-1/PD-L1 inhibitors in advanced NSCLC patients after platinum-based therapy.
Read MoreJapan has approved Medtronic’s Symplicity Spyral renal denervation system, expanding global access to the minimally invasive hypertension treatment.
Read MoreRegulatory clearance makes Paradise Ultrasound Renal Denervation the first approved device for resistant hypertension in Japan.
Read Morewith the aim of rapidly advancing the practical applications of Canon Medical’s Photon-Counting CT
Read More
